Reitan Colleen F is a director of Myriad Genetics, Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
ALNYLAM PHARMACEUTICALS, INC.
20 May 24
4
MYRIAD GENETICS INC
2 Jun 23
4
ALNYLAM PHARMACEUTICALS, INC.
19 May 23
4
MYRIAD GENETICS INC
3 Jun 22
4
ALNYLAM PHARMACEUTICALS, INC.
20 May 22
4
ALNYLAM PHARMACEUTICALS, INC.
19 Jul 21
4
MYRIAD GENETICS INC
4 Jun 21
4
MYRIAD GENETICS INC
7 Dec 20
4
ALNYLAM PHARMACEUTICALS, INC.
6 Jul 20
4
MYRIAD GENETICS INC
6 Dec 19
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
16 May 24 | ALNY Alnylam Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 151.22 | 5,228 | 790.58 k | 5,228 |
1 Jun 23 | MYGN Myriad Genetics | Common Stock | Grant | Acquire A | No | No | 0 | 15,151 | 0.00 | 72,850 |
18 May 23 | ALNY Alnylam Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 189.87 | 3,454 | 655.81 k | 3,454 |